Live Quote · NASDAQANTXHealthcare· Biotechnology

AN2 Therapeutics, Inc.

$5.08▼ 2.68%($-0.14)
MKT CAP $192.75MNEXT EARNINGS Mar 31, 2027
50%
Bullish
TickerSpark Score
67/100
▌ Solid
70
Valuation
20
Profitability
60
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ANTX research report →

Analyst Price Target
$9.00+77.2% vs. today

Range $9 – $9

Analyst RatingBuy
5 Buy3 Hold0 Sell

Price Chart

+370.37% · this period
$6.28$3.66$1.03Nov 20May 26Nov 20
52-Week Range66% of range
Low
$1.00
Current
$5.08
High
$7.19